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Introduction
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Co-Issue Editors, Yale Journal of Biology and Medicine, New Haven, Connecticut
The Yale Journal of Biology and Med-
icine (YJBM) publishes articles on basic
science and clinical medicine. In this issue,
we have identified a field that bridges these
two realms. Biomedical engineering is a
discipline that successfully brings clinical
applications from the bench to the bedside
by taking engineering principles and ap-
plying them to biological systems and clin-
ical disorders. This nascent field seeks to
use engineering as the bridge between basic
engineering, biological sciences, and the
clinical applications that are often consid-
ered the end product of such research. 
In  biomedical  engineering,  the  first
step is to identify a potential problem in a
physiologic system that can benefit from
tools outside of the realm of basic science
or clinical medicine. In particular, biomed-
ical engineering differs from most basic bi-
ological research in that it seeks solutions
based on engineering principles. 
Next,  biological  engineers  define
boundaries and variables associated with the
defined physiologic problem. What are the
potential weaknesses of various approaches?
Are there current physiologic systems in
place that can be utilized for other purposes?
In this vein, Padmanabhan and Gonzalez de-
fine the role of the extracellular matrix in
neutrophil  transmigration,  a  process  that
leads to inflammation. The understanding of
transmigration, cellular matrices, and eluci-
dation of their function is essential when
considering drug delivery methods to in-
flamed tissues that utilize the neutrophil
transmigration pathway and machinery. The
hypothetical roadway leading to otherwise
difficult-to-reach tissues is thus mapped;
now engineers must utilize this infrastruc-
ture to facilitate drug delivery. Gavrilov and
Saltzman describe another potential system
that  exploits  an  existing  system:  using
siRNA to control gene translation. Such con-
trol can lead to desired and controlled out-
comes in the cell, but as with other potential
treatments born of biomedical engineering,
siRNA treatments struggle with the problem
of proper delivery. Gavrilov and Saltzman
explore the knowledge and drawbacks of de-
livery methods for siRNAs and where the
field is headed in attempting to enhance and
target delivery. Doucet, Lam, and Griffin
take this one step further in their description
of the parameters for mimicking natural neu-
romuscular stimulation in order to promote
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repair in nerve-damaged muscles of stroke
and spinal cord injury patients. Once again,
we see the application of an engineering ap-
proach to fixing a clinically relevant problem.
Once the research boundaries have been
identified, the researchers may attempt to com-
putationally model the system, as Di Achille
and Humphrey model intracranial aneurysms.
These models have the benefit of displaying
physical strengths and weaknesses of a system
in an organized, significant, and non-invasive
way.
The final step takes the biological, en-
gineering, and computational aspects of re-
search and combines them into a cohesive
treatment with clinical applications. Dean,
Udelsman, and Breuer define a method of
tissue-engineered vascular grafts in pediatric
patients that is able to utilize the body’s nat-
ural ability to heal in such a way to minimize
scar tissue and maximize efficiency of graft
transfer.  Forrest  explores  a  different  ap-
proach and discusses transcatheter aortic
valves  used  to  mimic  and  replace  heart
valves in patients with the hope of improv-
ing the health and lives of patients with aor-
tic stenosis.
The articles in this focus topic represent
snapshot images of fields of study at various
phases along the spectrum from basic re-
search at the bench to relevant applications
in the clinic. Biomedical engineering is a dis-
cipline that focuses on treatment and imple-
mentation. It effectively synthesizes various
disciplines to tackle clinically relevant prob-
lems. While the focus topic articles all share
a biomedical engineering theme, they also
represent exemplary samples of research in
the fields of computational biology, cardiol-
ogy, immunology, pharmacology and drug
delivery, and neurology. As such, biomedical
engineering represents a fine example of a
node of convergence on the interconnected
network of biological and scientific research.  